Accelerating elimination of onchocerciasis in Cameroon
In Cameroon, onchocerciasis (river blindness) is endemic in all ten regions,
with approximately six million people infected, or about 60% of the population.
GLIDE is collaborating with Ministry of Health in Cameroon that jointly works with the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) and the Catholic University of Central Africa (UCAC) to support a study on community attitudes and perceptions towards mass drug administration (MDA) with ivermectin. The findings of the study will help to inform National Onchocerciasis Programme on barriers and challenges and identify opportunities for the Programme to facilitate greater levels of community involvement.
Bridges to Development
Our partnership with Bridges to Development explores integrated approaches to health to deliver improved disease elimination and eradication efforts.
In 2022, GLIDE partnered with APLMA-APMEN to support the elimination of malaria and lymphatic filariasis efforts in the Asia-pacific.